GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
China flag China · Delayed Price · Currency is CNY
13.24
-0.20 (-1.49%)
Aug 24, 2026, 3:00 PM CST

SHA:600771 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
66.263.0474.4590.08-250.02-316.24
Depreciation & Amortization
44.5244.5253.5446.0139.2538.39
Other Amortization
4.054.050.612.553.123.14
Loss (Gain) From Sale of Assets
--0.02-0.20.02-0.4
Asset Writedown & Restructuring Costs
18.9118.914.710.0219.890.03
Loss (Gain) From Sale of Investments
2.262.267.73-1.450.924.22
Provision & Write-off of Bad Debts
-0.08-0.0869.3624.7622.2-26.03
Other Operating Activities
-16.19.1423.6923.0851.848.14
Change in Accounts Receivable
-82.05-82.05289.01221.08352.25228.78
Change in Inventory
10.9810.98-204.87-157.6-59.639.76
Change in Accounts Payable
126.45126.45-190.49-25.6686.1155.62
Operating Cash Flow
175.81197.89112.39215.5253.4381.37
Operating Cash Flow Growth
50.02%76.07%-47.85%-14.96%211.45%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-6.03-6.24-8.78-2.51-8.67-18.19
Sale of Property, Plant & Equipment
--0.040.230.030
Investment in Securities
9.84-0.141.560.350.2-0.55
Other Investing Activities
-60.18-10.17-0.741.020.86
Investing Cash Flow
-56.36-16.55-7.17-1.19-7.41-17.89

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-19.9411.77-51.62206.5
Long-Term Debt Issued
---56355301.86
Total Debt Issued
19.9419.9411.7756406.62508.36
Short-Term Debt Repaid
-----229.5-288.22
Long-Term Debt Repaid
--18.53-254.37-242.98-260.32-309.8
Total Debt Repaid
-18.53-18.53-254.37-242.98-489.82-598.02
Net Debt Issued (Repaid)
1.411.41-242.61-186.98-83.19-89.67
Common Dividends Paid
-1.19-1.19-3.95-14.33-19.8-18.31
Other Financing Activities
10.25-0.22-0.23---
Financing Cash Flow
10.470-246.78-201.31-102.99-107.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
129.92181.34-141.5613143.03-44.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
169.78191.65103.61212.99244.7663.17
Free Cash Flow Growth
57.81%84.97%-51.35%-12.98%287.44%-
Free Cash Flow Margin
11.79%14.00%8.48%16.59%21.65%7.40%
Free Cash Flow Per Share
0.350.400.180.430.500.13
Levered Free Cash Flow
206.24195.4383.83164.65553.83-124.2
Unlevered Free Cash Flow
207.7219787.85175.23566.93-112.27

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
203.35185.57144.31142.15111.09126.71
Change in Working Capital
56.0456.04-121.7230.64366.21370.13